Oxford University to accelerate T1D research and care with £10m gift
30 September 2025
The University of Oxford has announced a gift of £10 million from the Bukhman Foundation to support ground-breaking research into type 1 diabetes. This generous funding will establish the Bukhman Centre for Research Excellence in Type 1 Diabetes, as well as create new academic posts and scholarships, helping to accelerate progress towards better treatments and ultimately a cure.
New research reveals optimal time intervals for COVID-19 vaccine boosters
18 September 2025
Two new papers from University of Oxford scientists have shown how the immune system reacts differently depending on the length of interval between vaccine doses.
New Podcast: Ebola virus persistence: implications for human-to-human transmission and new outbreaks
12 September 2025
A conversation with Miles Carroll and Oliver Meek about their recent Ebola virus persistence review article.
Respiratory syncytial virus vaccine linked to reduced dementia risk
25 June 2025
A new study, co-led by researchers at the Centre for Human Genetics, shows that a vaccine against respiratory syncytial virus (RSV) is associated with a 29% reduction in dementia risk in the following 18 months. The findings suggest a novel explanation for how vaccines produce this effect.
Three CHG Group Leaders awarded Associate Professor title
21 May 2025
We are delighted to announce that Gavin Band, Katherine Bull and Lahiru Handunnetthi have been awarded the title of Associate Professor, in recognition of their outstanding contributions to science and teaching.
Single cell biology of coeliac disease
7 May 2025
Research at the Centre for Human Genetics contributes to a study that identifies key immune structures in the gut that may drive coeliac disease.
Common virus may improve skin cancer treatment outcomes
1 May 2025
May is Skin Cancer Awareness Month, and a new study with input from researchers in the CHG has revealed that a common virus may positively influence how skin cancer patients respond to current treatments.
David Church awarded a Cancer Research UK Senior Cancer Research Fellowship
25 March 2025
David Church received a Senior Cancer Research Fellowship from the Cancer Research UK Research Careers Committee to study MHC-I and MHC-II dysregulation in colorectal & endometrial cancer.
Study finds previously unidentified genetic determinants of rare disease
28 February 2025
A landmark study involving researchers from the Centre for Human Genetics has identified 69 previously unidentified genetic determinants of rare disease, including uncommon forms of epilepsy and schizophrenia.
At-home test could play key role in type-1 diabetes screening
17 February 2025
A new home test to diagnose type-1 diabetes (T1D) is being investigated in a major UK study led by researchers at the National Institute for Health and Care Research (NIHR) Oxford Biomedical Research Centre and NDM's Centre for Human Genetics.